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Adherence to Physiotherapy
Introduction
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treatment and management of people
with cystic fibrosis is that of educator,
clinician, researcher and manager.
Physiotherapy has been defined by the
Chartered Society of Physiotherapy as a
health profession which emphasises the
use of physical approaches in prevention
and treatment of disease and disability
(csR leel).
Cystic fibrosis is a complex multi-slstem
disorder presenting many challenges.
It is the most common life-threatening
recessively inherited genetic disease of
caucasian popularions, with a carrier rate
of 1 in 25 and an incidence of I in 2,4{X}
live births (CFT, 1997). There are
approximately 7,5OO people *ith c-vstic
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fibrosis in the United Kingdom. The
median survival time has improved
dramatically and average life expectancr
is at least 40 years for children born in the
1990s (Elborn et al,1991). \mong peoplr
with cystic fibrosis there is a rride rangr 
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Phpiotherapv is time consuming and
and Quality of Life for
Adults and Adolescents with by Christine Ireland
Cystic Fibrosis
Summary There is indisputable evidence of the positive affects of empowering patients through
education in order to improve adherence to treatment and health outcomes. Considerable work
has been reported on how adults learn and this can be used as a framework by physiotherapists.
It is important that the increasing treatment burden for people with cystic fibrosis is effectively
evaluated to ensure that therapeutic levels of treatment are established through evidence-based
research to encourage maximum patient adherence and develop professionalisation.
With increasing age, care becomes more complex, presenting patients with the dilemma of
adhering to time-consuming treatments which have a considerable impact on their quality of life.
Poor adherence to physiotherapy has been reported in several studies in spite of its recognised
benefit in reducing lung damage and increasing exercise tolerance. There is little research on the
impact of physiotherapy on quality of life and the need when planning treatment to understand
patients' health beliefs and locus of control, or of the possible variations in adherence throughout
the course of the disease. Cross-sectional studies have focused on the reasons why physiotherapy
is not done.
Recently adherence has been defined and recognised as rarely perfect. lf no discernible improvement
in quality of life is evident then adherence to physiotherapy is unlikely to continue, irrespective of
advice.
Until recently, the lack of validated cystic fibrosis specific questionnaires meant that few studies have
been conducted to establish the impact of the disease and its treatment on patients' quality of life.
This review highlights the need for physiotherapists to undertake longitudinal studies on individually
tailored evidence-based treatment, accommodating patients' health beliefs in order to improve
adherence to physiotherapy and potentially their quality of life.
Ireland, C (2003).
'Adherence to
phlsiotherapy and
quality of life for
adults and
adolescents with cr'stic
fibrosis', Phtsiotheta,pt,
89,7,397-407.
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one of the least liked aspects of treatment
(Davids and Henley, 1990). Pryor and
Webber (1998) have stated that physio-
therapy regimens have been developed in
different parts of the world 'to provide a
means of treatment that does not require
assistance and thereby improves patient
compliance'. The aim of physiotherapy is
to teach patients how to self-manage their
condition through aftway clearance
techniques, posture correction and
exercise in order to lead as normal and as
healthy a life as possible. This is a daily
task and at times onerous. Among adults
and adolescents with cystic fibrosis non-
compliance can be a serious problem that
minimises the benefits of good medical
care (Fong et al,1990).
Very little has been written about the
developing multi-dimensional role of
physiotherapists in relation to patients
with chronic disease and their families.
Decclache (1995) states that there is
indisputable evidence of the positive
effects of patient teaching and education
in the knowledge of the disease and its
treatment, health behaviour, adherence
and health outcomes. In the education
field much work has been carried out into
how adults learn and this can be used
as a framework from a physiotherapy
perspective. Vinette Cross (1996) in her
study explores the concept of introducing
learning contracts into physiotherapy
clinical education as 'an example of the
humanistic orientation of self-directed
learning'. Learning contracts have been a
well-established tool in many areas of
education. Both Brookfield (1986) and
Knowles (1990) saw learning contracts
as a key principle in the enhancement
of self-directed learning. These concepts
can be equally applied to patient and
professional education.
Patient education, adherence to treat-
ment and its impact on quality of life and
health status has been a feature of the
increasing professionalisation of physio-
therapy where patients are seen more
as partners in the planning of their
treatment. Richardson (1999) considers
that: 'Taking responsibility for profes-
sionalisation must be perceived as integral
to being a physiotherapist and the spur to
continuing professional development
over the professional life span.'
Most research work on professional
effectiveness and development has been
carried out by nurses although it can, in
principle, be related to physiotherapy.
However, this imbalance is being add-
ressed and a growing interest can be seen
in the physiotherapy literature. Cystic
fibrosis provides an ideal example of
the developing professional role of
physiotherapists.
The study of cystic fibrosis provides a
fascinating insight into the advances in
medicine (Super, 1992). Busch (1986)
noted in his study into the history of
cystic fibrosis that, in the 19th century,
references were made in the medical
literature to 'the child that tastes salty
when kissed who will die in the first year
of life'. However, it was not until 1938 that
Dorothy Anderson described the disease
accurately and comprehensively. By the
1960s the estimated median survival time
for children born with cystic fibrosis
was less than five years. Death resulted
from persistent chest infections, and
malnutrition as a result of poor fat ab-
sorption was also a significant contrib-
uting factor.
Towards the end of the 1980s the
median life expectancy of patients with
cystic fibrosis had advanced to the mid
20s. By 1985 Tsui had discovered the cystic
fibrosis gene, the first heart/lung
transplant was carried out on a cystic
fibrosis patient, and advances in inhaled
antibiotics (Hodson et al, 7984) led to a
reduction in respiratory infections. These
clinical milestones led to an increase in
longevity and improved quality of life.
However, according to Conway et al
( 1996) the complexity and time-
consuming nature of daily drug and
physiotherapy regimens needed by
adult patients discourage adherence
to prescribed treatments. In addition,
patients with diabetes require insulin
and those with poor nutrition need
supplements or enteral feeding. Dodd
and Webb (2000) emphasised that as the
treatment burden increases, the patiens'
lifestyle becomes more complex. Cystic
fibrosis treatment is expensive; non-
adherence can waste resources, reduce
quality of life and lead to increased
hospital admissions.
Demanding treatment programmes
challenge both patiens and professionals,
particularly as there is no recognised
cure for c\.stic fitrrosis. \Iore recent
Pbwiotheraov lulv 2003u vol 89/no7
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studies have combined natural and social
science models where objective treatment
outcomes are evaluated with quality of life
measures to discover the impact of the
disease and its treatment on individuals
and consequently the professional role of
physiotherapists.
Humanity
The 'humanity of cystic fibrosis' has been
described by Barbero (1996) with an apt
quote from Robert Louis Stevenson: 'Life
is often about playing well with half a
deck of cards'. Barbero (1996) also states
that 'as care givers we can keep faith with
our patients, and as science progresses we
can give them hope; and, above all, we
can ensure that all that we do is done with
charity'. \{hile advances had been made
in the natural sciences resulting in
patients living into their mid 40s and
beyond, greater understanding of human
nature and insights into 'the real world' as
experienced by patients is required in
order to improve adherence. More
empirical studies have been undertaken,
taking into account both qualitative and
quantitative data, in order to provide a
greater understanding of the disease from
the patienls' perspective.
By the late 20th century, international
law recognised the increasing significance
of individuals with the drafting of the
United Nations Universal Declaration of
Human Rights (1948), the World Health
Organisation Alma-Ata Declaration for
Primary Health Care (1978) and the
diverse medical/humanitarian aspects of
the United Nations with the formation of
the United Nations Office for the Co-
ordination of Humanitarian Affairs in
1992. This humanitarian perspective can
be applied to cystic fibrosis where greater
emphasis is now being given to the impact
the disease has on the individual and
consequently the professional role of
physiotherapists.
In modern times science is highlY
esteemed (Chalmers, 1982). However,
the physiotherapy profession has
been disadvantaged by its historical
background of a lack of research and
failure to recognise the significance of
epistemology. This imbalance is being
corrected with the promotion of the
concept of the'practitioner-scientist'
(Robertson, 1996). Previously, emphasis
has been given to 'belief in treatment. As
Newham (1997) states: 'Belief is inevitable
and often valuable, but it must not be
confused with knowledge, which can only
be gained through scientific inquiry.'
Increasing emphasis needs to be placed
on the practical application of phys-
iotherapy based on sound scientific
knowledge and evidence-based practice.
An example of this is the Clinical Guide-
lines for the Physiotherapy Management of
Cystic Fibrosrs (2002) developed by the
Association of Chartered Physiotherapists
in Cystic Fibrosis, in a move towards
evidence-based practice.
In scientific studies the gold standard is
the randomised control trial. However,
this has proved problematical for
physiotherapists. Prassad and van der
Schans reviewed physiotherapy studies for
the Cochrane Institute (2000) and found
that due to the lack of randomised
control trials many of the studies did not
stand up to scientific scrutiny and were
therefore excluded. Valid and reliable
measurement tools need to be developed
to evaluate physiotherapy effectively.
Developing Role of Physiotherapists
Physiotherapy has become an accepted
part of life for patiens with cystic fibrosis
(Webber and Pryor, 1993). Physiother-
apists provide an ongoing education
programme to ensure maximum fitness,
effectiveness and efficiency of treatment.
They function as teachers,/practitioners
and have been described as professionals
whose occupational commitment involves
them in both the practice of their branch
of skills and in teaching carers about their
role (|arvis and Gibson, 1985). They also
need to teach postgrad-uate healthcare
professionals, medical and nursing staff.
Treatment
In the 1960s, when virtually all patients
were children, physiotherapy was carried
out in special schools where the children
were educated. Their lifestyle was limited
and treatment regimens were uncom-
plicated, requiring little in the way of
patient education programmes.
By the 1980s treatment became more
complex with the introduction of
intravenous and nebulised drugs
administered at home (Dodd and Webb,
2000). Physiotherapy became more
dynamic with increasing emphasis on
exercise, and a greater range of airway
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clearance methods, including the active
cycle of breathing techniques, were more
actively promoted for cystic fibrosis
patients.
By the 1990s home-based treatment for
some patients extended from day into
night. Overnight feeding was initiated,
insulin and dietary control were required
for those with diabetes, evident in 75%
of the adult population aged 30 and over
(Betts, 1998). From a physiotherapy
perspective recently there has been a
greater awareness of musculoskeletal and
incontinence issues. Treatment has
become more complex and time
consuming. Abbott et al (1996) suggested
that partial or non-adherence to
treatment might be the Product of
patients striking a balance between
treatment regimens and their quality of
life.
Little attention however has been paid
among physiotherapists as to how adults
learn. A greater awareness of patient
education needs to be encouraged as part
of increasing professionalisation and to
ensure that physiotherapy is as effective
as possible.
Evidence-based Practice
It is important that the increasing burden
of treatment is evaluated effectively to
ensure that physiotherapy is evidence-
based. Bithell (2000) has described
evidence-based practice as the integration
of 'clinical judgement with both
quantitive and qualitative evidence
seeming at present to be of most rel-
evance to physiotherapy. It represents a
radical shift away from the traditional
paradigm of knowledge based on the
"expert's" authority and clinical exper-
ience towards a new understanding'. It is
essential to establish therapeutic levels of
treatment which will bring about a clinical
improvement or prevent deterioration in
order to improve patient adherence.
Patient-centred treatments represent a
paradigm shift away from professionally
driven agenda towards a more balanced
partnership.
Patients as Partners
Empowerment of patients is encouraged
in recent government policy (NHSE,
1999) and the Chartered SocietY of
Physiotherapy which emphasises in its
Core Standards of Physiotherapy Practice
(2000: 8.1) that patients should be
'fully involved in any decision-making
process during treatment planning'. The
National Health Service Executive (1999)
emphasises the patient partnership
strategy to promote patients' involvement
in their own healthcare by functioning as
active partners with professionals. This
can be seen as a means of empowering
patients.
Giving patients knowledge and em-
powering them implies that they are
better equipped to participate in their
own healthcare. Giving patients know-
ledge also implies learning for which
patient education strategies need to be
developed. Willingness and ability to
learn has been the topic of much
educational research. The emphasis
on evidence-based practice, through
research, for the benefit of patients and
subsequent improved clinical effect-
iveness results in the increasing develop-
ment of the profession (Richardson,
1999). The development of education
strategies will encourage patients to direct
their own care.
Adherence
i,vi;il";ii;' il;ft;;ils"ffiA;;ilt ;T F;pi;
with cystic fibrosis greater attention has
been paid not just to the treatment itself
but how much of the recommended
treatment is actively practised by patients.
In the 1970s few lived to adolescence
(Czajkowski and Koocher, 1987). Most
treatments were carried out by parents,
whose intentions would predominate.
However, by the mid 1980s 50Vo of cystic
fibrosis patients were surviving to 20 or
more years and 35Vo were older than 30
years (Matthews and Drotar, 1984).
Improved care and greater quality of life
coincided with an explosion of knowledge
in both the natural and social sciences.
Patients were living longer but an ever-
increasing demand was placed upon
them to undertake time-consuming and
complex treatments.
Compliance
In the 80s the social sciences studies in
cystic fibrosis began to develop with
greater attention paid to quality of life
and health status, and what the disease
meant to the patients themselves. The
terms'compliance' and'adherence' were
often used interchangeably in the medical
literature. The term 'compliance' has
been dehned as the disposition to follow a
Dl'-i^rlraanv I''1r 9OO1 'r'nl RQ no 7
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prescribed regimen or specific instruc-
tions, as those of a physician to a patient(Churchill's Medical Dictionary, 1989).
Compliance, defined as the degree of
patient adherence to medical advice and
treatment regimens, may be an important
factor in successful management of the
disease (Abbott et al, 7994). Hwss et al
(1997) outlined the negative connotation
of the word. Compliance implies a
passivity assumed by patients. In moving
away from this passivity the term
'adherence'began to be used.
Adherence has been defined as the act
or quality of sticking to something
(Dorlands Medical Dictionary, 2000). This
connotation is more positive, implying a
voluntary active role for patients and
collaboration in management. It is more a
negotiated arrangement with a desired
effect of agreement by both sides with
the aim being to encourage greater
adherence and potentially an improve-
ment in the parienrs' quality of life. If
they cannot detect any improvement
they are unlikely to continue treatment,
in spite of physiotherapists' or doctors'
advice (Abbott et al, 1997). There is no
conclusive link between poor treatment
adherence and progression of the disease,
but it would be logical to assume that it
would be clinically detrimental (Abbott el
al, 1994). Studies by Davids and Henley
(1990), Abbott et al (1994), Conway et at(1996) and Walters (2001) state that
adherence to physiotherapy treatment in
cystic fibrosis patients is 50-75%.
In the 1990s studies began to be carried
out into adherence and quality of life. A
pilot study conducted by Carr et al (1996)
proposed that the majority of patients
held positive beliefs about physiotherapy
and exercise and the benefits they
obtained from them. However, the
opinions of non-responders (46%) could
not be accounted for and consequently
the results could be biased. Further
investigations would be needed to
establish whether patients with strong
positive health beliefs abour physiother-
apy had a strong internal locus of control
in their overall health (Carr et al, Igg6).
By the late 1990s Lask (1997) recog-
nised that total adherence was abnormal
and unrealistic. He emphasised that it was
naive to assume that adherence can ever
be complete and recommended that
reasonable degrees of adherence were
acceptable, otherwise conflict and tension
resulted which would ultimately be
detrimental to the relationship between
the health carers and the patient.
'Concordance', described by Mullen(1997) as the 'frank exchange of in-
formation, negotiation and a spirit of co-
operation' requires a non-judgemental
approach from professionals to im-
plement such a cultural change in the
patient/professional relationship. This is
particularly true in view of the consid-
erable burden of complex treatment for
people with cystic fibrosis. Although
controversial, there is some evidence
that cystic fibrosis patients do adhere
reasonably well to the enormous demands
made on them.
Abbott et al (1995) examined the
relationship between the medical and
paramedical staffs' views of whether
patients were adhering to treatment, the
patients' own self-reported adherence
levels. and those of carers, parents or
friends. The presenting of prescriptions
was one of the measures used to indicate
adherence to treatment. This information
was then compared with the physicians'
impressions. However, the validity of
prescription fulfilment as an outcome
measure could be questioned; although
collected, medication might not always be
put to use.
The studies carried out have been cross-
sectional in time and as yet no long-
itudinal studies have been conducted
giving recognition to the possible
variation in adherence throughout
disease progression and the impact
this would have on the patients' quality
of life.
Ha;iffi st;tfi" ' '
The terms 'quality of life' and 'health
status' are often used interchangeably.
Quality of life in this study will be
considered in terms of the broader
impact that disease has on patients'
lives and from patients' perspectives,
while health status will be considered
in terms of a more functional concept of
doing/not doing something. This
framework is defined from a clinician's
perspective. In cystic fibrosis the majority
of studies have been undertaken from
a quality of life perspective and this
will be the terminology used.
In the 1980s psychologists and psych-
iatrists first started to become involved
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with patients who had cystic fibrosis and
greater attention was given to individuals'
The initial work was conducted on
children and their families. Social science
assessment methods were used, with one
of the first being the Medical Compliance
Incomplete Stories Test (Koocher, 1982;
Cz{kowski and Koocher, 1987). Objective
measures such as arterial blood gases and
pulmonary function tests were used to
determine the relationship between
objective measurements and adherence.
Interviewing and social surveys were the
favoured tools of social scientists.
By the 1990s a wider perspective was
taken with emphasis notjust on social and
psychological dysfunction but on the
'quality' of added years. This resulted in
considerable interest in quality of life
studies (Congleton et al, 1996; Abbott et
at, 1997; Stabb et al, 1998; Qdttnet et al,
2000).
Previously quality of life studies
had used chronic respiratory disease
questionnaires such as the St George's
Respiratory Questionnaite (Jones et al,
1992) but they were neither sensitive
enough nor specific to the multi-
dimensional aspects of cystic fibrosis. This
was highlighted by Abbott et al (7997)
who sought to define quality of life in
people with cystic fibrosis and attempted
to measure it. She stated that: 'The aim of
the quality of life measurement in cystic
fibrosis should be to quanti$ and evaluate
the impact of both the disease and its
treatment on the wider aspects of the
patient's life.'
There has been a developing interest in
the added 'quality years' to the lives of
cystic fibrosis patients. The measuring of
quality of life (Abbott et a\,1997) needs to
result in an outcome that is meaningful to
health professionals and to patients and
their families, complements existing
clinical measures, and is an effective way
of determining the impact of treatments
on how patients feel and function' It can
also provide information for policy
makers who are interested in the impact
of expensive treatments.
None of the varied aPProaches to
measuring health related quality of life'
until very recently, has been specifically
valid for use in the United Kingdom for
people with cystic fibrosis. There are
three approaches to measuring health-
related quality of life: generic, utility and
disease specific.
Generic Measures
Generic measures are wide-ranging and
aim to define the health of populations
from the patients'persPective in
numerical terms, covering a wide range of
clinical groups which can then be
compared to healthy groups. Typical
examples are the Sickness Impact Profile
(Bergner et al, 1981), the Nottingham
Health Profile (Hunt and McKenna, 1991;
Wane and Sherbourne, 1992) and the
Short-Form 36-item (SF-36) questionnaire
(Brazier et al, 1992). These questionnaires
have established validity and reliability
and are used to obtain factual inform-
ation on a wide variety of diseases, yet can
be insensitive to the changes resulting
from an alteration in the disease state,
making interpretation diffi cult.
Utility Measures
The European Quality of Life Instrument
(Euro QoL Group, 1990) and the Quality
of Well-Being Scale (KaPlan and
Anderson, 1987) are utility measures
which are a useful device for purchasers
of healthcare as they can provide a cost
comparison of the same intervention with
different diseases. Most recently Walters
(2001) used the EQ5D version of the
EuroQoL instrument in her millennium
survey. However, utility measures are
limited in their range of sensitivity and
inadequate for providing suitable
measures to reflect disease progression.
Disease Specific Measures
Disease specific measures lend themselves
more readily to longitudinal studies,
which can reflect the changing pattern of
the disease and evaluation of treatment.
The Chronic Respiratory Questionnaire(Guyatt et al, 1987), the St George's
Respiratory Questionnaire (Jones et al,
1992) and the Asthma Quality of Life
Questionnaire (Juniper et al, 1992) have
been validated in other respiratory disease
groups but they have not been validated
for use in cystic fibrosis. However
Quittner et al (2000) have produced a
validated questionnaire specific to cystic
fibrosis for use in the United States of
America based on the work of Hertry et al
(1996) in France.
The first disease specific tool designated
for people with cystic fibrosis and
validated for use in the United Kingdom
was published by Gee et al (2000) who
produced a cystic.fibrosis health related
ph-^i^rha*nv T,rlv 9OO8 /vol 89 /no 7
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quality of life questionnaire. Its devel-
opment was patient led; perceived areas
of concern to adults and adolescents with
cystic fibrosis were identified by the
patients themselves, and contributed to
the development of this questionnaire as
an effective measurement tool.
By combining both the natural and
social sciences a more detailed under-
standing of the objective disease process
and the implications it has on the 'reality'
of the disease will enable a more
structured approach to cystic fibrosis to
be developed and consequently point the
way to a better future. Knowing why
people do not adhere to treatment may
lead to greater vcctlracy in predicting
which patients are likely to waver. This
will enable an education programme
to be individually tailored to improve
adherence to physiotherapy and promote
a better quality of life.
Patient Education
fiii: iaiyji l;; ri;;i;ii ;til;;i;ii il;fi;;
two-way communication and it is crucial
for physiotherapists to be aware of and
understand patients' health beliefs, their
locus of control, and their perception of
cystic fibrosis. Only then can programmes
be made appropriate and relevant to the
patients' perceived needs.
Moreau (2002) highlighted the imp-
ortance of a patient's health beliefs when
he stated that they 'determine his
response to illness or the threat of illness.
His health beliefs tend to enhance his
willingness to learn.'
Moreau (2002) also defined the
patient's locus of control as 'a patient's
perception of his ability to bring about
change'.
-fhe Core Standards of Physiotherapy
Practice (CSP, 2000) look for a greater
perception by physiotherapists of patients'
needs, by acknowledging factors such as
culture, lifestyle and preferences, when
defining the most appropriate plan of
care (Mead, 2000). To this end, physio-
therapists and patients need to collab-
orate in planning a treatment programme
(Carc et aL,7996).
Education is an increasingly significant
feature in the treatment and management
of long-term diseases. Decclache (1995)
stated that: 'For many years, patient
education has been limited to considering
only compliance and coping factors
related to the patient him or herself, and
features of the disease and treatment.
Knowledge of disease or treatment, ability
to cope, self-efficacy, health locus of
control, and degree of acceptance of
illness, are some of the many factors
that have been taken into account
in designing and carrying out patient
education work.'
However, for some patients the usual
methods of patient education, ie books,
videos or the internet, may be inadequate
as denial is a significant feature of their
coping strategies. To ignore the disease
and recommended treatments enables
them to get on with their lives until they
can no longer do so. For these patients
establishment of realistic health beliefs is
essential if their adherence to treatment is
to change.
Health education has been defined by
Ewles and Simnett (1995) as planned
opportunities for people to learn about
health and to undertake voluntary
changes in their behaviour, while health
promotion has been defined by the World
Health Organisation as 'the process of
enabling people to increase confol over,
and to improve their health' (WHO,
1984) . Physiotherapists require an
understanding of adult learning theory in
order to develop educational strategies to
improve adherence.
Adult Learning and Andragogy
The concepts of adult education were
initially recognised and developed by
John Dewey. His work Experience and
Education (1938) was a major exponent of
progressive education. Dewey identified
teachers' leadership responsibilities as
being in a partnership with learners.
Since the 1970s adult education has
been a source of increasing interest
as educationists and psychologists
have complemented each other's work.
Educationists such as Malcolm Knowles,
Robert Gagne, Paulo Freire and Jack
Mezirow began to develop educational
theories, while the humanistic psycho-
logist Carl Rogers emphasised the self-
actualisation of adult learners flarvis,
1995). Learning theorists had previously
focused their research on childhood and
adolescence. The development of adult
education was influenced by humanistic
perspectives. Malcolm Knowles (1989) was
one of the earliest humanistic educ-
ationists to distinguish adult learners from
child-centred educational perspectives. To
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identi$z the concept he coined the term
'andragogy', a derivative of the Greek
'aner' meaning man, and it was first used
in an education context in the mid-19th
century in Europe.
Although Knowles' theories have been
under considerable discussion, credit has
to be given for recognising the separate
identity of adult learning and teaching.
Knowles placed significant emphasis on
the 'self' and further recognition has
been given to this in healthcare in the
1990s by recognising the concept of
patient 'empowerment' and having
patient-directed health education
programmes.
This humanistic approach to education
recognises the empowerment of the adult
as a feature of the learner. The learner-
teacher is more of a partnership. This is a
different approach from the pedagogical
perspective, where health professionals
take an authoritative approach and the
Iearners a correspondingly more passive
role.
Jarvis (1995) described adult instructors
as 'andragogical teachers' who had
become the managers and designers of
the learning process and the learning
contract. Freire focused on the relation-
ship between learners and teachers and
drew attention to the role of teachers as
facilitators who can stimulate the learning
process, rather than imposing the correct
'knowledge' and values that have to be
acquired. Placing value on the 'humanity'
of the teacher,/learner relationship
reflects the emphasis given to the
patient/professional relationship in the
medical context (Mead, 2000).
This approach shows an increasing
emphasis on individuals and how their
experience of a process will influence
their learning. It is from these per-
spectives that educational strategies for
cystic fibrosis patients can be developed
in order to improve adherence to
physiotherapy with recognition given to
the distressing nature of the disease and
the impact it would have on a learning
process.
Discussion
Aa'il;;;;; i,iii' # ;;ilp;d-il;a ii;ii.ii;;i
improvement is not detectable by the
patients or they are not convinced that
deterioration is a result of neglecting
treatment.
Treatment and management Prog-
rammes have been dominated by pro-
fessionals. If they are not established in
partnership with patients, then adherence
may well be compromised. If they are to
adhere to treatment it is important to
establish the patients' health beliefs in
order to plan patient-centred treatment
programmes. Additionally, provided
patients are making informed decisions
and not coping by means of a denial
strategy, if they decline treatment their
wishes must to be respected. Patients
need to take responsibility for their own
healthcare.
Educational strategies must be designed
to empower patients to take more control.
Patient empowerment will help them to
influence the course of their disease, their
treatment programme and consequently
the impact the disease has on their quality
of life. Supported independence, en-
couraged through educational strategies
based on the humanistic principles
of the teacher/pupil being an equal
partnership, needs to be developed.
Quality of life is a very complex
parameter to measure objectively. It will
vary over time. There may not be a direct
link belween adherence to physiotherapy
and improved quality of life until
therapeutic levels of treatment are
established. The multi-factorial aspects of
the disease, the large numbers of variables
involved and the difficulty in designing
measurement tools provide researchers
with challenge.
Physiotherapists are actively involved in
teaching patients, yet little attention has
been paid in the profession to andragogy.
A greater awareness of patient education
needs to be encouraged as part of in-
creasing professionalisation and to ensure
high standards of clinical practice.
Conclusion
Ct'iil nff;;i''il ;; ; ;ffiii;ilsiils't"d i;
both treatment of the disease and the
professional development of physiother-
apists. In this complex multi-system
disease considerable medical advances
have resulted in an improved qualiq' and
length of life. The disease provides an
excellent example of both natural and
social sciences playing a significant part
in treatment and management. With
increasing longevity, greater acknowledge-
ment is given to the 'humanity' of cystic
fibrosis and the impact treatments have
on the patientsl quality of life. As
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physiotherapists have a greater under-
standing of the health beliefs and 'social
reality' of cystic fibrosis, a deeper insight
from the patients' perspective can be
gained. This information can be used in
planning patient-centred treatment
programmes where patients and prof-
essionals function in an equal partner-
ship. As patients are empowered to take
responsibility for their treatment the
potential exists to improve adherence to
treatment as a step towards mitigating the
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